Back to Journals » Drug Design, Development and Therapy » Volume 13

AR-42: A Pan-HDAC Inhibitor with Antitumor and Antiangiogenic Activities in Esophageal Squamous Cell Carcinoma

Total article views   HTML views PDF downloads Totals
6,396 Dovepress* 5,735+ 890 6,625
PubMed Central* 661 156 817
Totals 6,396 1,046 7,442
*Since 19 December 2019

View citations on PubMed Central and Google Scholar